Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index; 31 of the 126 sources its claims cite were checked for support.
Abstract
Human gut microbiota is able to influence the host physiology by regulating multiple processes, including nutrient absorption, inflammation, oxidative stress, immune function, and anabolic balance. Aging is associated with reduced microbiota biodiversity, increased inter-individual variability, and over-representation of pathobionts, and these phenomena may have great relevance for skeletal muscle mass and function. For this reason, the presence of a gut-muscle axis regulating the onset and progression of age-related physical frailty and sarcopenia has been recently hypothesized. In this narrative review, we summarize the studies supporting a possible association between gut microbiota-related parameters with measures of muscle mass, muscle function, and physical performance in animal models and humans. Reduced muscle mass has been associated with distinct microbiota composition and reduced fermentative capacity in mice, and the administration of probiotics or butyrate to mouse models of muscle wasting has been associated with improved muscle mass. However, no studies have targeted the human microbiome associated with sarcopenia. Limited evidence from human studies shows an association between microbiota composition, involving key taxa such as Faecalibacterium and Bifidobacterium, and grip strength. Similarly, few studies conducted on patients with parkinsonism showed a trend towards a different microbiota composition in those with reduced gait speed. No studies have assessed the association of fecal microbiota with other measures of physical performance. However, several studies, mainly with a cross-sectional design, suggest an association between microbiota composition and frailty, mostly assessed according to the deficit accumulation model. Namely, frailty was associated with reduced microbiota biodiversity, and lower representation of butyrate-producing bacteria. Therefore, we conclude that the causal link between microbiota and physical fitness is still uncertain due to the lack of targeted studies and the influence of a large number of covariates, including diet, exercise, multimorbidity, and polypharmacy, on both microbiota composition and physical function in older age. However, the relationship between gut microbiota and physical function remains a very promising area of research for the future.
Overview
CoChat Summary
TL;DR
This narrative review summarizes animal and human evidence for a gut-muscle axis linking gut microbiota to muscle mass, muscle function, and physical frailty/sarcopenia in aging. It concludes that the association is biologically plausible and supported by limited studies, but causality remains uncertain because targeted human studies are lacking and many covariates confound both microbiota and physical function.
Key findings
- Animal studies support a possible gut-muscle axis: reduced muscle mass has been associated with distinct microbiota composition and reduced fermentative capacity in mice, and probiotics or butyrate administration improved muscle mass in mouse models of muscle wasting.
- No studies have targeted the human microbiome specifically associated with sarcopenia; limited human evidence shows associations between microbiota composition, involving taxa such as *Faecalibacterium* and *Bifidobacterium*, and grip strength.
- In a randomized controlled trial of 60 nursing home residents, a prebiotic containing inulin and fructooligosaccharides improved hand-grip strength after 13 weeks (12.4 ± 3.2 vs. 10.2 ± 4.1 kg, p = 0.04), although fecal microbiota composition was not assessed.
- Frailty, mostly assessed by the deficit accumulation model/Rockwood Frailty Index, was associated with reduced microbiota biodiversity and lower representation of butyrate-producing bacteria; one trial in 50 nursing home residents found a mild but statistically significant reduction in a 62-item frailty index after prebiotic administration.
Methods
- Narrative review; papers searched on PubMed as of 1 June 2019 using terms including microbiota AND “muscle function,” sarcopenia, “muscle mass,” “muscle wasting,” frailty, “gait speed,” “muscle strength,” “grip strength,” and “physical performance.”
- A systematic review approach was not possible due to the low number of human studies and heterogeneity of settings, participants, and outcome measures; human studies relevant to the primary aim were discussed, with animal studies included for possible pathophysiological mechanisms.
- The review summarizes studies on microbiota-related parameters with measures of muscle mass, muscle function, and physical performance, including grip strength, gait speed, timed up-and-go, and frailty indices.
Limitations
- The paper states that the causal link between microbiota and physical fitness remains uncertain due to lack of targeted studies and the influence of many covariates, including diet, exercise, multimorbidity, and polypharmacy, on both microbiota composition and physical function in older age.
- The paper states that most human studies are cross-sectional, so causality cannot be inferred; no human studies have directly assessed an association between gut microbiota composition and skeletal muscle mass in age-related sarcopenia.
- The paper states that frailty studies mostly used the Rockwood Frailty Index or Clinical Frailty Scale, which do not directly assess muscle function and performance; gait speed studies were not focused on older people with sarcopenia or physical frailty and did not follow geriatric assessment recommendations.
- Evident from the text: this is a narrative rather than systematic review, with a search limited to 1 June 2019, and much of the mechanistic evidence comes from animal models whose translation to humans is uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
16 Valid · 6 Not valid · 66 Not checked · 21 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Healthy, active older subjects, including centenarians, show a microbiota composition resembling that of adult subjects, with limited features of dysbiosis [45,46].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 1. Introduction > 1.2. Gut Microbiota: A Novel Player in Sarcopenia and Physical Frailty?
What the sources say
- Partly supportedcites [45] Kim S. Jazwinski S.M. The gut microbiota and healthy aging: A mini-review Gerontology 2018 64 513 520 10.1159/000490615 30025401 PMC6191326 sourceExperimental — accuracy not yet measured
In “The human gut microbiota” (page unavailable), the review says young adults and centenarians share a core microbiota, supporting a limited resemblance. But “Changes in the gut microbiota associated with longevity or healthy aging” (page unavailable) reports age-related compositional differences; it does not establish that healthy, active older people have an adult-like overall composition or only limited dysbiosis. (LLM, conf=0.84)
- Disputedcites [46] Biagi E. Nylund L. Candela M. Ostan R. Bucci L. Pini E. Nikkïla J. Monti D. Satokari R. Franceschi C. Through ageing, and beyond: Gut microbiota and inflammatory status in seniors and centenarians PLoS ONE 2010 5 e10667 10.1371/annotation/df45912f-d15c-44ab-8312-e7ec0607604d 20498852 PMC2871786 sourceExperimental — accuracy not yet measured
The Discussion (page not supplied) says young and elderly adults have comparable gut microbiota, but explicitly says centenarians differ significantly from the adult-like pattern and have lower diversity. The fecal-profile results likewise report significantly different microbiota profiles in centenarians. Thus the source contradicts the claim’s inclusion of centenarians. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Namely, the circulating levels of microbiota-derived indoxyl sulfate are positively associated with the expression of myostatin and atrogin-1 [29], representing two of the main negative regulators of skeletal muscle mass [30].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 1. Introduction > 1.2. Gut Microbiota: A Novel Player in Sarcopenia and Physical Frailty?
What the sources say
- Partly supportedcites [29] Enoki Y. Watanabe H. Arake R. Sugimoto R. Imafuku T. Tominaga Y. Ishima Y. Kotani S. Nakajima M. Tanaka M. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1 Sci. Rep. 2016 6 32084 10.1038/srep32084 27549031 PMC4994088 sourceExperimental — accuracy not yet measured
The Results (page not available in our copy) show that administering indoxyl sulfate increased myostatin and atrogin-1 expression in the skeletal muscle of half-nephrectomized mice. They do not establish a positive association between circulating indoxyl sulfate levels and expression: plasma trough levels only tended to rise in treated mice (p = 0.15). The cited study used administered indoxyl sulfate rather than testing a microbiota-derived exposure. (LLM, conf=0.86)
- Supportedcites [30] Sakuma K. Yamaguchi A. Sarcopenia and cachexia: Tha adaptations of negative regulators of skeletal muscle mass J. Cachexia Sarcopenia Muscle 2012 3 77 94 10.1007/s13539-011-0052-4 22476916 PMC3374017 source
The citation to this paper is attached to the description of myostatin and atrogin-1 as negative regulators of skeletal muscle mass, not to the preceding indoxyl-sulfate association, which cites [29]. The Sarcopenia section explicitly calls Atrogin-1 and myostatin common negative regulators; it does not need to establish the indoxyl-sulfate association to support the part attributed to [30]. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the administration of probiotics or butyrate to mouse models of muscle wasting has been associated with improved muscle mass”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > Abstract
What the sources say
- Partly supportedcites [66] Varian B.J. Goureshetti S. Poutahidis T. Lakritz J.R. Levkovich T. Kwok C. Teliousis K. Ibrahim Y.M. Mirabal S. Erdman S.E. Beneficial bacteria inhibit cachexia Oncotarget 2016 7 11803 11816 10.18632/oncotarget.7730 26933816 PMC4914249 sourceExperimental — accuracy not yet measured
The Results (Figure 1; page unavailable) report improved muscle measures in a mouse model of cancer-associated cachexia after treatment with the probiotic L. reuteri. The Experimental design section describes L. reuteri administration, but our copy provides no evidence that butyrate was administered or improved muscle mass (searched: butyrate). (LLM, conf=0.88)
- Partly supportedcites [67] Bindels L.B. Beck R. Schackman O. Martin J.C. De Backer F. Sohet F.M. Dewulf E.M. Pachikian B.D. Neyrinck A.M. Thissen J.P. Restoring specific Lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model PLoS ONE 2012 7 e37971 10.1371/journal.pone.0037971 22761662 PMC3384645 sourceExperimental — accuracy not yet measured
The Results report that two Lactobacillus strains increased tibialis muscle weight by 8% in leukemic mice, although gastrocnemius weight did not change significantly. This supports the probiotic part of the claim for specific strains and one muscle; our copy does not report butyrate administration or its effect on muscle mass (searched: butyrate). (LLM, conf=0.88)
- Partly supportedcites [71] Walsh M.E. Bhattacharya A. Staranatarajan K. Qaisar R. Sloane L. Rahman M.M. Kinter M. Van Remmen H. The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging Aging Cell 2015 14 957 970 10.1111/acel.12387 26290460 PMC4693467 sourceExperimental — accuracy not yet measured
The section “Butyrate prevents hindlimb muscle loss during aging” reports that aged mice given butyrate lost less hindlimb muscle mass than controls. The Experimental procedures describe a butyrate-containing diet, not probiotic administration; our copy does not support the probiotic part of the claim. (LLM, conf=0.89)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Finally, transplantation of the intestinal microbiota from pigs to lean germ-free mice resulted in significant changes of muscle fibers structure, resembling to that typical of pigs [51].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 2. Gut Microbiota and Muscle Mass > 2.1. The Microbiota as Transducer of Nutrient Signals
What the sources say
- Partly supportedcites [51] Yan H. Diao H. Xiao Y. Li W. Yu B. He J. Yu J. Zheng P. Mao X. Luo Y. Gut microbiota can transfer fiber characteristics and lipid metabolic profiles of skeletal muscle from pigs to germ-free mice Sci. Rep. 2016 6 31786 10.1038/srep31786 27545196 PMC4992887 sourceExperimental — accuracy not yet measured
The Results section ('The two groups of mouse recipients developed different body compositions, fiber characteristics and fiber type distributions') confirms that GF BALB/C mice colonized with porcine fecal suspension mirrored their pig donors in fiber type: MYH7 (slow type I) was higher and MYH4 (fast IIb) lower in RM versus YM at p < 0.05, and the Discussion states RP/RM exhibited higher type I and lower type IIb fibers. However, the morphological 'structure' measures the claim names — fiber diameter and cross-sectional area of the gastrocnemius — were only non-significant trends in both donors (p = 0.0994) and recipients (p = 0.0832), so 'significant changes of muscle fiber structure' overstates the source. Our copy also does not describe the germ-free recipients as 'lean'; the lean/obese contrast applies to the Yorkshire vs Rongchang pig donors. (LLM, conf=0.75)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The effects of protein intake on the gut microbiota composition, and the consequences for muscle mass deposition, may depend on protein quality and microbiota metabotype [54], so that the pro-anabolic response to protein intake, mediated by the microbiota, may be different on an individual basis.”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 2. Gut Microbiota and Muscle Mass > 2.1. The Microbiota as Transducer of Nutrient Signals
What the sources say
- Partly supportedcites [54] Liao Y. Peng Z. Chen L. Zhang Y. Cheng Q. Nüssler A.K. Bao W. Liu L. Yang W. Prospective views for whey protein and/or resistance training against age-related sarcopenia Aging Dis. 2019 10 158 174 10.14336/AD.2018.0325 30705776 PMC6345331 sourceExperimental — accuracy not yet measured
The section ‘Gut microbiota: a key factor for whey protein and/or resistance training against age-related sarcopenia?’ says protein quality affects gut microbiota in mice and discusses ways microbiota may influence skeletal muscle. It does not establish that the consequences for muscle mass deposition depend on protein quality or microbiota metabotype; the copy provides no page number for these passages. (LLM, conf=0.84)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
63 more claims · 7 with their cited sources checked
Create a free account to see all 109 claims and to verify the 95 references still open.
- It may state two separate claims as one. 37
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Anabolic resistance is associated with reduced gene expression in proteins involved in MPS, impaired protein absorption and digestion, loss of skeletal-muscle stem cells, and decreased amino-acid transportation in the skeletal muscle [19,137,138].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredIn the citing paper
“Gut microbiota dysbiosis is linked to age-related systemic inflammation, leading to impaired muscle function and increased proinflammatory cytokines, which are associated with higher risk of obesity [19].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 3. Gut Microbiota and Parameters of Muscle Function > 3.3. Gut Microbiota and Other Parameters of Physical Performance
“Similar intervention studies were performed in healthy adults, evaluating physical performance by measuring endurance capacity, which is not part of standard geriatric assessment [88,109].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 3. Gut Microbiota and Parameters of Muscle Function > 3.1. Gut Microbiota and Muscle Strength
“In another experimental study, the administration of resveratrol, a polyphenol compound able to promote skeletal and cardiac muscle cell biogenesis and remodeling, to mouse models of heart failure resulted in significant changes in intestinal microbiota composition, but no improvement in muscle strength [88].”
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503 · cited 1×
“This condition frequently overlaps with physical frailty [3], representing the reduction of the capacity to maintain fitness, physical performance and sense of well-being over time and particularly after stressors such as acute illnesses [4].”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803 · cited 1×
“fractures, disability and mortality [1,2].”
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314
Guralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Cited by
Items 201–300 of 418
Diabetes-induced muscle wasting: molecular mechanisms and promising therapeutic targets
Qiao, R., Guo, J., Zhang, C., Wang, S., Fang, J., Geng, R., Kang, S., Huang, K., & Tong, T. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2382348 · Cited by 18
“The human gut microbiota exerts critical influences on numerous physiological processes in the host, including nutrient absorption, inflammation, oxidative stress, immune function and metabolic balance, through multiple pathways (Ticinesi et al. 2019).”
Guo, H., Cao, J., He, S., Wei, M., Meng, D., Yu, I., Wang, Z., Chang, X., Yang, G., & Wang, Z. (2024) · JMIR Aging · doi:10.2196/58175 · Cited by 21
“It is well established that lean body mass is critical to health, yet the effectiveness of protein interventions in increasing lean body mass remains inconsistent [21,22].”
Redman, J. S., Kaspar, M., & Puri, P. (2021) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-20-236 · Cited by 12
“There is evidence now that the microbiome may also predispose to sarcopenia (64).”
BackgroundOhira, T., Ino, Y., Kimura, Y., Nakai, Y., Kimura, A., Kurata, Y., Kagawa, H., Kimura, M., Egashira, K., Matsuda, C., et al. (2021) · npj Microgravity · doi:10.1038/s41526-021-00164-6 · Cited by 14
Gut Microbiota, Mild Cognitive Impairment and Dementia: A Systematic Review
Tana, C., Moffa, S., Tana, M., Ucciferri, C., & Moffa, L. (2025) · Neurology International · doi:10.3390/neurolint17100155 · Cited by 15
Self-citationThe association between dietary fiber intake and sarcopenia
Kao, C.-C., Yang, Z., & Chen, W. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105437 · Cited by 14
The possible role of gut microbiota dysbiosis in the pathophysiology of delirium in older persons
Ticinesi, A., Parise, A., Nouvenne, A., Cerundolo, N., Prati, B., & Meschi, T. (2023) · Microbiome Research Reports · doi:10.20517/mrr.2023.15 · Cited by 15
Self-citationEmerging nanotherapeutic strategies targeting gut-X axis against diseases
Sun, A., Liu, H., Sun, M., Yang, W., Liu, J., Lin, Y., Shi, X., Sun, J. Y., & Liu, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115577 · Cited by 14
Shih, L.-C., Lin, R.-J., Chen, Y., & Fu, S. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-023-00587-w · Cited by 19
“In a separate study, Lachnospiraceae were found to be associated with gait speed and physical frailty 48 .”
BackgroundGuo, Y. P., Wang, Q., Lv, Y., Xia, F., Chen, X., Mao, Y., Wang, X., Ding, G., & Yu, J. (2024) · Aging · doi:10.18632/aging.205501 · Cited by 21
“Therefore, it has been proven that various age-related conditions, such as frailty and sarcopenia, are associated with the gut microbiome [17, 18].”
Otsuka, R., Zhang, S., Furuya, K., Tange, C., Sala, G., Ando, F., Shimokata, H., Nishita, Y., & Arai, H. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112080 · Cited by 12
“…sympathetic nervous system regulation, and fat accumulation regulation and may be useful in preventing sarcopenia by suppressing energy metabolism and skeletal muscle degradation (Ticinesi et al., 2019; Gómez-Cortés et al., 2018; Prokopidis et al., 2020; Lustgarten, 2019; Chen et al., 2022).”
BackgroundMiso, fermented soybean paste, suppresses high-fat/high-sucrose diet-induced muscle atrophy in mice
Hashimoto, Y., Okamura, T., Bamba, R., Yoshimura, Y., Munekawa, C., Kaji, A., Miki, A., Majima, S., Senmaru, T., Ushigome, E., et al. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.23-36 · Cited by 14
Gut microbiota disturbances in hospitalized older adults with malnutrition and clinical outcomes
Fernández, S. S. M., Garcez, F. B., de Alencar, J. C. G., Bastos, A. A., Morley, J. E., Cederholm, T., Aprahamian, I., de Souza, H. P., Avelino‐Silva, T. J., Bindels, L. B., et al. (2024) · Nutrition · doi:10.1016/j.nut.2024.112369 · Cited by 15
Asaoka, D., Toda, K., Yoshimoto, S., Katsumata, N., Odamaki, T., Iwabuchi, N., Tanaka, M., Xiao, J., Nishikawa, Y., Nomura, O., et al. (2025) · Nutrients · doi:10.3390/nu17101746 · Cited by 14
“A systematic review and fecal metagenomic analysis further reported a consistent decrease in SCFA-producing bacteria and associated functional genes involved in SCFA synthesis, carotenoid and isoflavone biotransformation, and amino acid interconversion in SA individuals [37,38].”
Should we Try to Alleviate Immunosenescence and Inflammaging - Why, How and to What Extent?
Witkowski, J. M., Bryl, E., & Fülöp, T. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191111153016 · Cited by 11
Functional capacity, sarcopenia, and bone health
Laskou, F., Patel, H. P., Cooper, C. C., & Dennison, E. M. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101756 · Cited by 17
Nakazeko, T., Shobako, N., Shioya, N., Iwama, Y., Hirano, Y., Fujii, S., Nakamura, F., & Honda, K. (2023) · Nutrients · doi:10.3390/nu15204317 · Cited by 13
“Although numerous studies have reported on the relationship between intestinal bacteria and frailty, it is still too early to say with certainty whether there is a cause or effect [19].”
BackgroundJung, S., Kim, S. H., Jeung, W., Ra, J., Heo, K., Shim, J.-J., & Lee, J.-L. (2021) · Applied Sciences · doi:10.3390/app11125386 · Cited by 11
Alessandro de, S. I. R. E., Mancuso, E., Marotta, N., Massimino, M., Zito, R., Averta, C., Bartalotta, I., Palummo, A., Cerantonio, A., Citrigno, L., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-24500-y · Cited by 12
Music-based interventions in the feeding environment on the gut microbiota of mice
Niu, J., Xu, H., Zeng, G., Wang, P., Raciheon, B., Nawaz, S., Zeng, Z., & Zhao, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-33522-3 · Cited by 12
“The type, distribution, function and characteristics of the GM vary in different animals and even in different ages of the same individual 5 .”
BackgroundAnalysis of intestinal flora in elderly Uygur patients with sarcopenia
Shan, Z., Cheng, N., Zhu, J., Chen, F., Ji, J., & Meilibana (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1097 · Cited by 10
“15 The composition of the intestinal flora has been confirmed to change with age from birth.”
BackgroundSun, X., Chen, S., Zhao, S., Wang, J., & Cheng, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1284472 · Cited by 11
Batitucci, G., Abud, G. F., Ortiz, G. U., Belisário, L. F., Travieso, S. G., Viliod, M. C. D. L., Venturini, A. C. R., & de Freitas, E. C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102460 · Cited by 13
Sarcopenic obesity and brain health: A critical appraisal of the current evidence
Booranasuksakul, U., Guan, Z., Macdonald, I. A., Tsintzas, K., Stephan, B. C. M., & Siervo, M. (2025) · Nutrition Bulletin · doi:10.1111/nbu.12725 · Cited by 10
Li, Y., Gong, Q., He, W., & Ke, J. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-05725-y · Cited by 13
“Dietary live microbes are known to modulate the composition and function of the gut microbiota, which plays a critical role in maintaining overall health, particularly in older adults [50].”
Jamshidi, S., Masoumi, S. J., Abiri, B., & Vafa, M. (2022) · Trials · doi:10.1186/s13063-022-06598-x · Cited by 11
Yang, Y., Deng, S., Wang, C., Wang, Y., Shi, Y., Lin, J., Wang, N., Su, L., Yang, F., Wang, H., et al. (2022) · The journal of nutrition health & aging · doi:10.1007/s12603-022-1875-8 · Cited by 10
“Age-related dysfunction in the gut microbiota may influence muscle health by regulating multiple processes, including nutrient absorption, inflammation, oxidative stress, immune function, and anabolic balance (23).”
Oliva, F., Bartoli, A., Garofalo, E., Calabrese, M., Oliva, G., & Maffulli, N. (2023) · Muscles Ligaments and Tendons Journal · doi:10.32098/mltj.01.2023.01 · Cited by 10
Risk of bias assessment tool for systematic review and meta-analysis of the gut microbiome
Lampeter, T., Love, C., Tang, T. T., Marella, A. S., Lee, H. Y., Oganyan, A. K., Moffat, D., Kareem, A., Rusling, M., Massmann, A., et al. (2023) · Gut Microbiome · doi:10.1017/gmb.2023.12 · Cited by 13
“The GMB changes with age across numerous conditions, disease models, and species impacting microbial diversity and biome composition (Ticinesi et al., 2019; Liu et al., 2020).”
BackgroundTherapeutic strategies to modulate gut microbial health: Approaches for sarcopenia management.
Das, S., Preethi, B., Kushwaha, S., & Shrivastava, R. (2024) · PubMed · doi:10.14670/hh-18-730 · Cited by 16
Identification of components from Aralia elata and their effects on muscle health and gut microbiota
Ko, H., Bekele, T., Le, T. T., Cha, K. H., Kim, S., Youn, H., Jung, S. H., & Kim, M. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106384 · Cited by 9
Lee, M., Chiu, C., Liao, Y.-C., Cheng, Y.-C., Lee, C., Ho, C.-S., Hsu, Y.-J., Chang, H.-Y., Lin, J., & Huang, C. (2024) · Current Research in Food Science · doi:10.1016/j.crfs.2024.100917 · Cited by 10
“This suggests that the gut microbiota can promote host protein anabolism by increasing amino acid bioavailability, insulin secretion, and skeletal muscle response (Ticinesi et al., 2019).”
Molecular mechanisms and therapeutic strategies of gut microbiota modulation in Sarcopenia (Review)
Yuan, C. (2024) · Oncology Letters · doi:10.3892/ol.2024.14850 · Cited by 9
“Clostridium species, including Clostridium symbiosum and Clostridium citroniae , are associated with increased relative abundance in individuals with sarcopenia, suggesting a potential role in the pathogenesis of the condition (44).”
Neto, N. J., Brito, M. D., Gomes, C. D. S., Corrêa, L. C. D. A. C., Guerra, G. C. B., & Guerra, R. O. (2025) · PLoS ONE · doi:10.1371/journal.pone.0313193 · Cited by 16
“The hypothesis that gut microbiota dysbiosis influences sarcopenia, osteoporosis, and osteosarcopenia in older adults is supported by emerging evidence linking age-related changes in the gut microbiome with musculoskeletal function [15].”
Yoshimura, Y., Wakabayashi, H., Nagano, F., Matsumoto, A., Shimazu, S., Shiraishi, A., Kido, Y., Bise, T., Hamada, T., Yoneda, K., et al. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.02.027 · Cited by 11
He, J., Li, J., Liu, J., & Liu, M. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1656834 · Cited by 9
Bhattacharya, S., Bhadra, R., Schols, A. M. W. J., & Sambashivaiah, S. (2020) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000688 · Cited by 10
“Increasing literature evidence identifies the gut microbial composition as a key contributor to skeletal muscle mass, metabolism and function during aging, and thus might be an important determinant in development of sarcopenia [5], giving rise to the concept of thegut– muscle axis.”
BackgroundFunctional Nutrients to Ameliorate Neurogenic Muscle Atrophy
Moresi, V., Renzini, A., Cavioli, G., Seelaender, M. C. L., Coletti, D., Gigli, G., & Cedola, A. (2022) · Metabolites · doi:10.3390/metabo12111149 · Cited by 10
Nguyen, N. B., Le, T. T., Kang, S. W., Hyun, K., Choi, S., Youn, H., Jung, S. H., & Kim, M. (2024) · Nutrients · doi:10.3390/nu16081130 · Cited by 10
“The gut–muscle axis, involving gut microbiota dysbiosis and sarcopenia, is a growing area of interest, particularly in older individuals [55]; however, its association remains unclear.”
BackgroundYang, X., Wang, Y., & Yang, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1421209 · Cited by 11
She, M., Li, T., Zhou, L., Deng, Z., Huang, M., Yan, Y., Zhang, M., Yang, Y., & Wang, D. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109940 · Cited by 12
Diet, the Gut Microbiome, and Estrogen Physiology: A Review in Menopausal Health and Interventions
Lim, M. J. S., Parlindungan, E., See, E., Gan, C. H., Yap, R., & Yong, G. J. M. (2026) · Nutrients · doi:10.3390/nu18071052 · Cited by 13
Glyphosate exposure, muscular health and functional limitations in middle-aged and older adults
Jauregui-Zunzunegui, S., Rodríguez‐Artalejo, F., Téllez-Plaza, M., & García‐Esquinas, E. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118547 · Cited by 12
Sanborn, V. E., & Gunstad, J. (2020) · Geriatrics · doi:10.3390/geriatrics5040063 · Cited by 8
Contemporary Advances in Sports Science
Taïar, R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.93203 · Cited by 8
Bo, F., Teng, H., Shi, J., Luo, Z., Xu, Y., Pan, R., Xia, Y., Zhu, S., Zhang, Y., & Zhang, W. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1354037 · Cited by 7
“…can increase intestinal permeability, which promotes the entry of endotoxins and other microbial products (e.g., lipopolysaccharides) into circulation (34), inducing muscle inflammation and insulin resistance, and therefore affect skeletal muscle metabolism and contractile function (14, 35).”
BackgroundSarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
Xu, J., Pan, Y.-K., Zhang, J. K., Dai, S., & Xu, L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1264205 · Cited by 12
“…or an increase in pro-inflammatory cytokines such as IL-6, IL-8, and TNF-α , causing persistent chronic inflammation, which is not only a vital pathogenic factor in causing muscle loss, but also an important molecular link between dysregulated intestinal microecology and sarcopenia (28).”
BackgroundHazra, R., Chattopadhyay, S., Mallick, A., Gayen, S., & Roy, S. (2024) · Medical Oncology · doi:10.1007/s12032-024-02416-3 · Cited by 8
Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
Abenavoli, L., Statsenko, M., Scarlata, G. G. M., Morano, D., Myazin, R. G., & Emelyanov, D. (2024) · Livers · doi:10.3390/livers4040035 · Cited by 9
“Myosteatosis contributes to functional muscle failure, which, in turn, raises the risk of mortality [16,19].”
Yan, S., Chai, K., Yang, J., & Wang, H. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02410-8 · Cited by 10
“Moreover, the potential influence of gut microbiota on frailty cannot be overlooked, as alterations in the microbiome are related to both lipid accumulation and frailty, suggesting a possible process in the pathogenesis of frailty [47, 48].”
Causal relationship between gut microbiota and ageing: A multi-omics Mendelian randomization study
Zhang, G., Lu, Y., Wang, Z., Ma, R., Jin, H., Zhang, J., Liu, F., & Ding, Y. (2025) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2025.105765 · Cited by 9
Yao, Q., Chen, L., Cai, Y., Li, C., Wen, S., Yang, C. Z., Zhang, Q., Zeng, Y., Zheng, S., Zou, J., et al. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.94335 · Cited by 6
“Bifidobacteria have also been recognized as an important factor in sarcopenia and frailty among older adults [45].”
BackgroundGut metagenomic features of frailty
Jarmukhanov, Z., Mukhanbetzhanov, N., Vinogradova, E. B., Kozhakhmetov, S., & Kushugulova, A. R. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1486579 · Cited by 7
“They manifest in declines in physical performance, such as reduced speed and overall physical function (Ticinesi et al., 2019).”
Yin, H., Qiu, Y., Gan, C., Zhou, Y., Chen, T., & Liang, M. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1562278 · Cited by 7
Zhu, S., Hao, D., Chen, Y., Shi, Z., Zhong, Y., Zhang, F., Tang, F., Wang, S., & Wu, Y. (2025) · Bone · doi:10.1016/j.bone.2025.117718 · Cited by 6
Age-driven dysbiosis: gut microbiota in the pathogenesis and treatment of aging disorders
Kopalli, S. R., Wankhede, N. L., Rahangdale, S. R., Sammeta, S. S., Aglawe, M. M., Koppula, S., Taksande, B. G., Upaganlawar, A., Umekar, M. J., & Kale, M. B. (2026) · Biogerontology · doi:10.1007/s10522-026-10389-1 · Cited by 7
A Blended Vitamin Supplement Improves Spatial Cognitive and Short-Term Memory in Aged Mice
Fukui, K., You, F., Kato, Y., Yuzawa, S., Kishimoto, A., Hara, T., Kanome, Y., Harakawa, Y., & Yoshikawa, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052804 · Cited by 6
“The maze apparatus constructed of acrylic resin (120 cm in diameter and 30 cm in height; #MWM-04M, Muromachi Kikai Co., Ltd., Tokyo, Japan) was used for the experiments.”
MethodCallegari, S., Mirzaei, F., Agbaria, L., Shariff, S., Kantawala, B., Moronge, D., & Ogendi, B. M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317018 · Cited by 7
“…including oxidative stress, mitochondrial dysfunction, senescent satellite cell accumulation, protein homeostasis imbalance, inappropriate diet, NAD+ deterioration, increased myostatin and GDF-15, immunosenes-cence, gut microbiota alteration, and hormonal deviations [29,30,39–43] (Figure 3).”
BackgroundSarcopenia and non-alcoholic fatty liver disease
Myazin, R. G. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-222-2-120-130 · Cited by 6
Sarcopenia and cognitive impairment
Jia, L., & Zhang, H. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.08.001 · Cited by 6
Bailey, S., & Fraser, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1229796 · Cited by 9
Association between exercise and changes in gut microbiota profile: a review
Khaledi, M., Darvishi, M., Sameni, F., Shahrjerdi, S., Karami, E., Barahui, N., Hemmati, J., Hasheminasab, M. S., Sanae, M.-J., Akhavan‐Sigari, R., et al. (2023) · Sport Sciences for Health · doi:10.1007/s11332-023-01132-1 · Cited by 7
“However, when evaluating the effects of prebiotic consumption on the Frailty index, the effect of direct prebiotic stimulation on mechanical contractions of the gut mediated by microbiota should also be regarded [63].”
Sarcopenic Obesity: The Underlying Molecular Pathophysiology and Prospect Therapies
Meiliana, A., Dewi, N. M., Defi, I. R., Rosdianto, A. M., Qiantori, A. A., & Wijaya, A. (2024) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v16i4.3176 · Cited by 7
“Dysbiosis of the gut microbiota is connected to the degree of inflammation (90), lifestyle, and antibiotics exposures.”
BackgroundYoshida, K., Kokubo, E., Morita, S., Sonoki, H., & Miyaji, K. (2024) · Nutrients · doi:10.3390/nu16244262 · Cited by 5
“Bifidobacterium counts decline with age and are also reduced in sarcopenia [1,33].”
Li, S., Huang, H., Shi, H., Chen, Z., Jiang, S., Yu, X., Ren, K., Huang, Q., & Zhao, Q. (2025) · Innovation in Aging · doi:10.1093/geroni/igaf065 · Cited by 5
Dong, R., Pan, J., Zhao, G., Zhao, Q., Wang, S., Li, N., Song, L., Huang, X., Miao, S., Ying, J., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1168049 · Cited by 6
“Bifidobacterium participates in the alleviation of oxidative stress (75) and the production of short-chain fatty acids (SCFAs) in the gut (76), and shows glycosidic activity in enhancing the bioavailability of isoflavone in vivo (77, 78).”
BackgroundMorgado-Cáceres, P., Huerta, H., Bergman, C., Figueroa, R., Farías, P., Quiroz, G., Woehlbier, U., Mella, K., Díaz-Rivera, O., Linsambarth, S., et al. (2025) · Aging and Disease · doi:10.14336/ad.2025.0188 · Cited by 7
Peng, X., Zhao, Y., Lin, T., Shu, X., Hou, L., Gao, L., Wang, H., Ge, N., & Yue, J. (2021) · PubMed Central · doi:10.7507/1001-5515.202101083 · Cited by 7
Impact of a Whole-Food, High-Soluble Fiber Diet on the Gut–Muscle Axis in Aged Mice
Fielding, R. A., & Lustgarten, M. S. (2024) · Nutrients · doi:10.3390/nu16091323 · Cited by 5
“The gut microbiome and its metabolic products are involved in mechanisms that impact skeletal muscle mass and physical function, which has been defined as the gut– muscle axis [7–11].”
BackgroundNon‐zero‐sum microbiome immune system interactions
Tuganbaev, T., & Honda, K. (2021) · European Journal of Immunology · doi:10.1002/eji.202049065 · Cited by 8
Timmis, J. K., Roussilhon, D. F., & van de Burgwal, L. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0050 · Cited by 5
Medication Management to Reduce Falls—With Particular Focus on Frailty, Polypharmacy and Prescribing
Umapathy, M., Narvaez-Vega, K., & Khoshnaw, H. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0989 · Cited by 4
He, H., Li, P., Wang, D., Du, J., Pa, L., Wang, H., Zhao, J., Peng, X., & Shan, G. (2023) · Global Transitions · doi:10.1016/j.glt.2023.08.003 · Cited by 9
Fang, T., Chiu, M., Huang, M., Dai, C., Yeh, Y., & Yen, J. (2024) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12823 · Cited by 4
“38 Mitochondrial and nuclear damage, decreased muscle-specific PGC-1 α , apoptosis pathway, MAFbx and MuRF-1-mediated ubiquitination, and TNF-α and INF-γ -induced inflammation all involve the mechanism of the development of sarcopenia.”
BackgroundJones, D. J., Celis-Morales, C. A., Gray, S. R., Morrison, D. J., Ozanne, S. E., Jain, M., Mattin, L. R., & Burden, S. T. (2024) · Nutrients · doi:10.3390/nu16091398 · Cited by 5
“It has also been suggested that these changes and deterioration of the gut microbiome in older age, may lead to changes in protein metabolism, absorption and bioavailability [14], resulting in reduced muscle protein synthesis [7], frailty [15] and sarcopenia [16].”
BackgroundMinawala, R., & Faye, A. S. (2024) · Advances in Geriatric Medicine and Research · doi:10.20900/agmr20240003 · Cited by 7
“Age-related changes in the gut microbiome, such as reduced microbial diversity, contributes to dysfunction of the gut mucosal barrier, leading to increased intestinal permeability and translocation of microbial byproducts [48].”
BackgroundDiminished representation of vitamin-B12-producing bacteria in constipated elders with frailty
Zhao, L., Deng, X., Ding, N., Liu, Y., Ma, Y., Li, J., Wang, S., Ji, X., Wang, J., Wang, D., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110403 · Cited by 4
Wang, Y., Sun, Y., & Liao, H. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04318-6 · Cited by 5
“…the gut microbiota remains challenging because of the inherent limitations associated with traditional observational and cohort studies, such as confounding factors in the long-term development of the disease and reverse causality (Chen et al. 2022a; Kragsnaes et al. 2024; Ticinesi et al. 2019).”
Ye, H., Meehan, D., Timmons, S., & O'Toole, P. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c00364 · Cited by 3
Hu, X., Guo, J., Wang, J., Liu, W., Xiang, X., Chen, S., Li, X., Tang, J., Zhang, W., Chen, H., et al. (2022) · Current Microbiology · doi:10.1007/s00284-022-03055-5 · Cited by 5
Wang, J., Chen, J., & Chen, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1056394 · Cited by 5
“It has been reported in the researches that different exercise lead to significantly differentiated abundances of the gut microbiota (Morita et al., 2019; Ticinesi et al., 2019), liver function and biochemical parameters in NAFLD patients (Golabi et al.”
BackgroundThe Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis
Jiao, H., Wang, H., Li, J. X., Yang, Z., & Sun, C. (2025) · Seminars in Liver Disease · doi:10.1055/a-2564-7551 · Cited by 4
“…the cross-sectional area of myotubes, which has a positively promoting effect on myogenesis Nishikawa et al, 47 Wang et al, 73 Mello et al, 92 and Ticinesi et al 93 Reviews on the relationship between intestinal barrier dysfunction and sarcopenia/frailty in patients with cirrhosis Dysfunction of…”
Ren, Y., Wang, L., Wang, D., Huang, J. J., Wang, O., & Ding, G. (2025) · Nutrients · doi:10.3390/nu17101734 · Cited by 4
“The age-related alterations in gut microbiota composition may contribute to the development of sarcopenia through the gut–muscle axis [40].”
Wang, R., Cao, L., Zhang, P., Chen, H., Zhong, Q., Sang, Z., Wu, C., & He, Z. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02744-x · Cited by 4
Barberá, A., Ortolá, R., Sotos‐Prieto, M., Rodríguez‐Artalejo, F., Moya, A., & Ruiz‐Ruiz, S. (2026) · Aging Cell · doi:10.1111/acel.70365 · Cited by 5
“Conversely, when alternative clinical measures were used to define FS, Claesson et al. (2012) demonstrated reduced species richness associated with increased functional dependence, highlighting the potential variability in gut microbiota responses to FS (Ticinesi et al. 2019).”
JIANG, H.-B., Zhang, J.-Q., Liang, H., Sun, L.-Y., Deng, C., & Yang, S. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1729870 · Cited by 8
The Gut–Muscle Axis in Sarcopenia: Mechanisms, Evidence Gaps and Translational Challenges
Marchitto, S. A., Abbatecola, G., Zeidan, R. S., Morgan, L., Calvani, R., Picca, A., Schlögl, M., Tosato, M., Leeuwenburgh, C., Anton, S. D., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14050976 · Cited by 4
“Crucially, sarcopenia is not merely associated with the loss of individual taxa but with broader alterations in relative abundance and microbial ratios that may compromise the stability of the intestinal environment [9,10,16].”
Dharmansyah, D., Rahayuwati, L., Defi, I. R., Pramukti, I., & Mutyara, K. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113247 · Cited by 6
Leflunomide-Induced Weight Loss: Involvement of DAHPS Activity and Synthesis of Aromatic Amino Acids
Guo, X., Wang, K., Chen, H., Wang, N., Qiu, D., Huang, H., Luo, J., Xu, A., Xu, L., Yu, Z., et al. (2024) · Metabolites · doi:10.3390/metabo14110645 · Cited by 3
Merelim, A. S., Zacca, R., Moreira‐Gonçalves, D., Costa, P., & Baptista, L. C. P. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1504786 · Cited by 3
Bilgin, S., Suzan, V., Kanat, B. B., Avcı, G. U., Avcı, S., Yavuzer, H., Bolayırlı, M., Döventaş, A., & Erdinçler, D. S. (2025) · Gerontology · doi:10.1159/000545939 · Cited by 3
“Owing to altered intestinal permeability, micronutrients, and metabolites produced by the gut microbiota, such as lipopolysaccharide (LPS) and short-chain fatty acids, can reach skeletal muscle and other tissues; they then regulate skeletal muscle health through multiple metabolic pathways [8, 11].”
InfluentialImprovements in Gut Microbiota Dysbiosis in Aged Mice Transplanted with Adipose-Derived Stem Cells
Liu, Z., Wang, T., Zhu, Y., Zhao, H., Zhou, Z., & Wu, Q. (2023) · Stem Cells and Development · doi:10.1089/scd.2022.0257 · Cited by 3
“A general consensus exists in the literature which indicates that aging is associated with compositional changes during gut microbiota dysbiosis [37– 39].”
Chae, S., & Lee, S. (2023) · Current Topic in Lactic Acid Bacteria and Probiotics · doi:10.35732/ctlabp.2023.9.2.45 · Cited by 4
Using multiomics to explore the weight differences between genders in Muscovy ducks
Tian, J., Tan, L., Wei, S., Zhu, W., Ji, C., Yao, Z., Xu, Y., & Nie, Q. (2024) · Poultry Science · doi:10.1016/j.psj.2024.103787 · Cited by 5
“In recent years, studies have found that the gut microbiota can in fl uence host physiology by regulating a variety of processes, including nutrient absorption, oxidative stress, immune function, and anabolic balance (Ticinesi et al., 2019; Xu et al., 2022).”
BackgroundLuo, J., Li, J., Wang, W., Zhang, R., & Zhang, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212310 · Cited by 4
“Cinnamoylglycine is typically formed through the metabolism of dietary polyphenols by gut microbiota, suggesting a potential role of dietary polyphenols or gut microbiota in maintaining muscle health [27].”
Suzuki, R., Sakata, N., & Fushimi, K. (2021) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14316 · Cited by 3
Zhang, P., Shao, L., Zhang, J., Wang, L., Pang, X., Tao, W., Fan, G., Peng, L., Kan, G., Li, W., et al. (2022) · JCSM Rapid Communications · doi:10.1002/rco2.60 · Cited by 4
“community composition and skeletal muscle has recently been investigated,(38,39) and reduced muscle mass was found to be closely correlated with a specific gut microbiome signature.(38,39) For example, muscle atrophy in ghrelin-null”
BackgroundKetogenic diet in treating sepsis-related acquired weakness: is it friend or foe?
Miao, Y., Xie, L., Chen, S., Zhang, X., Liu, W., & Xie, P. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1484856 · Cited by 7
Wang, H., Wei, X., Liu, S., Guo, T., Yu, P., Li, G., & Zhou, Z. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.144890 · Cited by 2
Bai, R., Pan, L., Huang, Y., Jiang, Z., Wang, J., Liu, Y., Huang, C., Zheng, X., Yu, Y., Li, Q.-Q., et al. (2025) · The Journal of Frailty & Aging · doi:10.1016/j.tjfa.2025.100118 · Cited by 4
“…can increase intestinal permeability and drive chronic inflammation, leading to higher levels of frailty-associated pro-inflammatory cytokines [52,53] Nor-ovirus infections often involve older adults with frailty, who are prone to more prolonged clinical courses [54] Previous studies also found…”
Metadata
- Authors
- Ticinesi, A., Nouvenne, A., Cerundolo, N., Catania, P., Prati, B., Tana, C., & Meschi, T.
- Affiliations
- University of Parma (IT)
- Ospedale di Parma (IT)
- Corresponding author
- Ticinesi, Andrea
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-07-17
- Volume
- 11
- Issue
- 7
- Pages
- 1633
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6683074
- OpenAlex
- W2961066137
- Semantic Scholar
- fecf6f6df4b36ccd42a489508be21efdeb7072a1
- Cited by
- 418
- References
- 144
- Citations by year
- 2026: 60 · 2025: 61 · 2024: 88 · 2023: 73 · 2022: 49 · 2021: 44 · 2020: 36 · 2019: 6
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- gut microbiota, aging, sarcopenia, physical frailty, muscle mass, muscle function, gut-muscle axis, microbiome diversity, butyrate, probiotics, Faecalibacterium, Bifidobacterium, grip strength, walking speed, parkinsonism, physical performance
- MeSH terms
- Gastrointestinal Microbiome, Frailty, Aged, Animals, Humans, Muscle, Skeletal, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
